BOBS(BOBS)
BOBS
Next earnings: Aug 6, 2026
Signal
Leaning Bearish1↓
PRICE
Prev Close
11.82
Open
11.53
Day Range11.41 – 12.02
11.41
12.02
52W Range9.74 – 23.49
9.74
23.49
16% of range
VOLUME & SIZE
Avg Volume
1.2M
Float
130.6M
FUNDAMENTALS
P/E Ratio
14.0x
Value territory
EPS (TTM)
$0.85
Div Yield
No dividend
Performance
1D
+0.76%5D
-4.34%1M↑
+0.93%3M↓
-40.69%6M
-30.02%YTD
-30.02%1Y
-30.02%Best: 1M (+0.93%)Worst: 3M (-40.69%)
Quick Read
Trend
DOWNTREND
Price below SMA50 & SMA200Momentum
NEUTRAL
46% gross marginValuation
FAIR
P/E 14x vs ~20x sectorHealth
WEAK
CR 0.9 (low) · FCF $0.74/shBearish
Key MetricsTTM
Market Cap$1.56B
Revenue TTM—
Net Income TTM—
Free Cash Flow—
Gross Margin45.7%
Net Margin5.1%
Operating Margin7.1%
Return on Equity38.8%
Return on Assets6.7%
Debt / Equity2.43
Current Ratio0.87
EPS TTM$1.10
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
2 strong1 watch3 concern
49/100Liquidity
0.87Concern
Leverage
2.43Concern
Coverage
18.4xStrong
ROE
38.8%Strong
ROIC
9.8%Watch
Cash
$53MConcern
ANALYST COVERAGE7 analysts
BUY
▲ +105.7%upside to target
L $14.00
Med $24.50consensus
H $26.00Stock Health
Composite Score
2 of 7 signals bullish
3/10
Trend
●
✗Trend StateDowntrend (below both MAs)
●
✗Above SMA 50$12.47 (-4.5%)
●
✗Above SMA 200$14.57 (-18.2%)
Technicals
●
✗MA AlignmentDeath Cross (50D vs 200D -14.4%)
Fundamentals
●
✓Last EarningsBeat estimates
●
✓Analyst ConsensusBuy
●
✗LiquidityCurrent Ratio 0.87 — liquidity risk
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentAug 31, 2026
In 107 days
FinancialsFull statements →
Technicals
Market Position
Price Levels
52W High
$23.49+97.2%
SMA 200
$14.57+22.3%
SMA 50
$12.47+4.7%
Current
$11.91
52W Low
$9.74-18.2%
52-Week RangeNear 52-week low
$9.7416th %ile$23.49
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 10 analysts
Analyst revisions:EPS↑ Revised UpRevenue↓ Revised Down
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $2.4B $2.4B–$2.4B | — | $0.96 | — | ±21% | High7 |
FY2026(current) | $2.6B $2.6B–$2.6B | ▲ +10.2% | $0.93 | ▼ -3.6% | ±2% | High10 |
FY2027 | $2.8B $2.8B–$2.8B | ▲ +7.2% | $1.06 | ▲ +13.9% | ±3% | High10 |
Range confidence:Tight (high)ModerateWide (low)
🔥Beat 4 consecutive quarters
Earnings HistoryBOBS
Last 4Q
+23.5%avg beat
Beat 4 of 4 quarters+17%
Q1'26
+7%
Q1'26
+42%
Q2'26
+29%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Insider Activity
SEC Filings →2 Buys/0 SellsNet Buying
NET BUYERS$303K bought · $0 sold · 30d window
Barton William GDir
$300K
May 8
BUY
Barton William GDir
$2K
May 12
BUY
Financials
INSTITUTIONAL OWNERSHIP
1
BAIN CAPITAL INVESTORS LLC
95.4M▲2
FMR LLC
5.2M▲3
Alyeska Investment Group, L.P.
2.5M▲4
Sunriver Management LLC
1.5M▲5
EMERALD ADVISERS, LLC
1.3M▲6
BALYASNY ASSET MANAGEMENT L.P.
1.3M▲7
CITADEL ADVISORS LLC
1.2M▲8
Point72 Asset Management, L.P.
1.2M▲News & Activity
BOBS News
About
No company information available